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Physical activityAbstract Objective: The aim of the present case–control study was to compare the quality-of-life
(QOL) and physical-activity (PA) data of exclusive-narghile-smokers (ENS) with age- and tobacco
quantity matched exclusive-cigarette-smokers (ECS).
Methods: Males agedP 20 years who are ENS or ECS for more than 10 years were recruited to
participate in this case–control study. Amounts of used tobacco (narghile-years (NY), pack-years
(PY)) were determined. QOL (symptoms, activity, impacts and total scores) and PA (daily, sport-
ing, leisure and PA scores) data were collected according the Saint-George’s-respiratory and the
Voorrips PA questionnaires. Student t-test and Chi-2 test were used to compare the profiles of
the two groups. Pearson correlation-coefficient (r) was used for evaluating the relationship between
used quantity of tobacco and PA and QOL data.
Results: Two age (44 ± 9 vs. 45 ± 14 years) and quantity of used tobacco (30 ± 32 NY vs. 37
± 34 PY) matched groups (63 ENS and 54 ECS) were compared. Compared to the ENS group, the
ECS group has a worse QOL with significantly higher activities, impact and total scores (respec-
tively, 22 ± 22 vs. 32 ± 25; 11 ± 12 vs. 23 ± 24 and 18 ± 14 vs. 28 ± 20), has significantly lower
sporting and PA scores (respectively, 12 ± 8 vs. 8 ± 6 and 17 ± 8 vs. 14 ± 7). There were clear






398 G. Ben Hadj Mohamed, H. Ben Saad(r= 0.46) scores and quantity of used cigarettes. However, no significant relationship was found
between quantity of used narghile and QOL or PA data.
Conclusion: Chronic exclusive narghile-use is less detrimental to PA and QOL than chronic
exclusive cigarette smoking.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
The last years have seen the emergence of large-scale narghile-
use [1,2]. This societal event has developed to a worrying extent
[1–4] and has become well-established as a documented reason
for chronic diseases, especially, cardiorespiratory [1–12].
To better explore the chronic effects of narghile-use on
health, it would be interesting to refer to the World-Health-
Organization’s (WHO) latest categorization of the usual his-
tory of chronic diseases (http://www.who.int/classifications/
icf/en/, Accessed January 9th 2016), which reports on three
evolutionary stages: deficiency, incapacity and handicap.
While the two first stages have already been extensively
explored [5–12], to the best of the authors’ knowledge, only
a few studies have raised the issue of the handicap (quality-
of-life (QOL) and/or physical-activity (PA)) of narghile-
smokers (NS) [12–15]. Their results are controversial.
In 2008, NitzanKaluski et al. [14] described the relationships
between PA, lifestyle determinants and obesity in Middle-East
schoolchildren aged 11–19 years. They found physical-
inactivity to be powerfully linked to narghile-use [14]. In 2009,
Tavafian et al. [15] investigated the relationships between
narghile-use and health-related-QOL (HRQOL) [16] of people,
agedmore than 15 years, in the general population of Iran. They
found statistically significant differences between NS (n= 172)
and non-smokers (Non-S; n= 1486) on all scales except for the
‘‘role emotional” [15]. In addition, they noted that narghile-use
was a risk factor for declining physical-component-summary
and mental-component-summary scores [15]. In 2012, Joseph
et al. [13] applied the clinical chronic-obstructive-pulmonary-dis
ease (COPD) questionnaire (CCQ) to describe the respiratory
QOL in the Lebanese population aged more than 40 years,
stressing on differences between smokers (NS and cigarette-
smokers (CS)) andNon-S. They noted that previous and current
CS vs. Non-S have significantly lower QOL in the same disease
category and that previous and current NS vs. Non-S have sim-
ilar QOL [13]. They also noted a clear dose–effect relationship
for the effect of all types of smoking on QOL, with lower
QOL scores in patients with heavier smoking cumulative doses.
A result was even found for current NS [13]. In 2014, Ben Saad
et al. [12] evaluated the PA [17] of Tunisian exclusive-NS (ENS),
aged 20–60 years. They found that one fifth of male ENS were
sedentary with a low total PA score [12]. They also found statis-
tically significant differences between healthy-Non-S (HNS)
group aged 40–60 years (n= 53) and an aged-matched sub-
group of ENS (n= 25) on all scores (sporting activity, leisure
activity and PA) except for daily activity score [12].
According to some guidelines [18,19], the aim of clinical con-
trol in patients with chronic disease includes HRQOL goals
(improve QOL and increase physical and emotional
participation in everyday activities) added to clinical goals.
The usefulness of QOL measures is indisputable in the field ofdescriptive epidemiology [18]. In clinical practice, it can
strengthen the doctor–patient relationship by emphasizing the
interest that is attached to the consequences of the disease/
symptoms on the subject’s daily life [18]. From a public health
viewpoint, it is central to determine the level of PA in order to
offer a hypothetical basis for the development of suitable poli-
cies and programs to improve health and avoid the many com-
plications that attend physical inactivity [14]. The PA remains
the best way tomaintain bodywellness, to ensure daily activities
and to keep good cardiopulmonary function and thus daily PA.
It is clear that narghile-use still harbors many deficiencies.
These were highlighted in the 2005-WHO advisory noted on
narghile-use [20] and they need to be studied further [2]. Thus,
the aim of the present case–control study was to compare the
QOL and PA data, evaluated according to validated question-
naires [17,21,22], of ENS with age- and tobacco quantity
matched exclusive-CS (ECS). The null hypothesis is that there
is no divergence between mean values of their records.
Subjects and methods
Type of study
This was a case–control study spread over 2 months (Decem-
ber 2013–January 2014). It was conducted in several cafe´s in
Sousse, Tunisia. The prevalence rates of smoking among males
living in Sousse were 13% for narghile and 40% for cigarette
(unpublished data). The study was conducted in agreement
with the Declaration of Helsinki. Participants provided oral
consent and the study procedure was accepted by the ethics
committee of the local hospital (approval number 2208/2014).
Sample size
The null hypothesis was H0: m1 = m2 and the alternative
hypothesis was Ha: m1 = m2 + d, where d is the difference
between two means and n1 and n2 are the sample sizes for
the ENS and ECS groups, such N= n1 + n2. The required
sample size was estimated using a specific formula [23]
(detailed in the Supplementary data section) to detect a differ-
ence between two means with a power of 85% and an a level of
5%. The total sample size for the study was 114 subjects (57
ENS and 57 ECS).
Population
Several special cafe´s, which NS and CS frequented in Sousse
city, were visited for this investigation. Only males aged
20 years and above, with a smoking history of more than ten
years, were included. In each cafe´, approximately five to ten
smokers were approached and studied. The ECS and ENS were
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(age, smoking type, duration and daily amount of tobacco
smoked) were documented with their oral consent. Then the
Voorrips’ PA-questionnaire (PAQ) [17] and the Saint-Geor
ge’s-respiratory-questionnaire (SGRQ) [21,22] were fulfilled.
Collected data
The following data were collected: subject characteristics (age,
occupation and education level); amount of used tobacco
(narghile-years (NY) and pack-years (PY)); type of narghile
tobacco smoked (Tabamel and/or Tombac and/or Jurak);
PAQ scores (daily, sporting, leisure and PA) and status [low
(non-active), moderate and high (active)]; SGRQ scores (symp-
toms, activity, impacts and total scores).
Applied questionnaires
After consenting to participate, each smoker was given three
questionnaires to complete and was instructed to ask the
researcher (GBHM) to clarify questions, which might have
appeared vague. Questionnaire responses were anonymous.
The three applied questionnaires were as follows:
A basic questionnaire for age, socioeconomic and schooling
levels (respectively, SEL and SL) and smoking status and
habits. Two (low and high) SL and SEL were defined [24].
Narghile-use, type of narghile tobacco used and cigarette con-
sumption were self-reported. The smoking histories were
defined as NY for ENS (number of narghile smoked a day -
 total number of smoking years) and PY for ECS (number
of packs smoked a day  total number of smoking years).
Three types of used narghile tobacco were evaluated: Moassel
and/or Tombac and/or Jurak [25].
An Arabic translated version of the Voorrips PAQ [17] was
filled out by each smoker. The questionnaire is divided into
three parts, evaluating each with different scores, three types
of PAs: daily, sporting and leisure activities. The three scores’
sum yields a total PA score [17]. This PAQ is used to classify
subjects in three categories according to the total PA score:
low (score < 9.4, showing a non-active lifestyle); moderate
(9.4 6 score < 16.5) and high (scoreP 16.5) levels. According
to the total PA score, two groups of subjects were arbitrary
defined [non-active (score < 9.4); active (scoreP 9.4)] [12].
An Arabic translated version of the SGRQ [21,22] was filled
out by each smoker. The SGRQ is a standardized self-
administrated airway disease-specific questionnaire divided into
three subscales: ‘‘symptoms”, ‘‘activity” and ‘‘impacts” (respec-
tively, 8, 16 and 26 items). For each subscale and for the overall
questionnaire, scores range from 0 (no impairment) to 100
(maximum impairment). A total score was calculated by adding
all the answers to the questionnaire and expressing the result as
a percentage of the maximum possible for the entire question-
naire. The maximum possible scores for ‘‘symptoms”, ‘‘activ-
ity”, ‘‘impacts” are, respectively, 662.5, 1209.1 and 2117.8
with a total maximum score of 3989.4. More information about
the SGRQ is included in the Supplementary data section.
Statistical analysis
Age, amounts of used tobacco, PAQ and SGRQ data distribu-
tions were normal and outcomes were expressed as mean± standard-deviation (SD) and 95% confidence-interval
(95% CI). SL, SEL and PA status are expressed as a number
(%). For PA and QOL data, a percentage of change was cal-
culated [=(ENS value  ECS value)/ENS value]. Student’s t-
test was used to compare means of quantitative data and
Chi-2 test was used to compare the profiles of the two groups.
The Pearson correlation-coefficient (r) was used to evaluate the
relationship between used quantity of tobacco and PAQ17 and
SGRQ [21,22] data (dose–effect). All statistical procedures
were performed using Statistica software (Statistica Kernel
version 6; Stat Software. France). Significance was set at the
0.05 level.
Results
One hundred seventeen subjects were included (63 ENS and 54
ECS).
The two groups were age-, SL- and SEL matched and their
means of used tobacco amounts were similar (Table 1). The
two most smoked types of narghile-tobacco were Tombac
and Moassel, respectively, in 41.3% and in 25.4% of subjects.
Almost one fourth of subjects smoked a mixture of narghile
tobacco (Table 1). Fig. 1 displays the used quantities of
tobacco by each group divided by age ranges. Fewer smokers
were included in the age ranges [20–30] years and P60 years,
respectively, 14 and 13 subjects. The amounts of used tobacco
were similar for the two groups regardless of age range.
Table 2 displays the PA scores and status of the two groups.
Compared to the ENS group, the ECS group has significantly
lower sporting and PA activity scores (percentage changes
were, respectively, +45% and +25%). However, they have
similar leisure and daily activity scores and include similar per-
centages of non-active and active smokers.
Table 3 displays the QOL data of the two groups. Com-
pared to the ENS group, the ECS one has significantly higher
‘‘activities”, ‘‘impact” and ‘‘total” scores (percentage changes
were, respectively, 45%, 115% and 56%). However, they
have similar ‘‘symptoms” scores.
Table 4 displays the ‘‘r” between used quantities of tobacco
and PAQ and SGRQ data (dose–effect) for the two groups.
There were clear, negative dose–effect relationships between
sporting, leisure and PAs scores and quantity of smoked cigar-
ettes (the higher the dose of cigarette smoking was, the lower
the PAs scores were). No significant relationship was found
between quantity of used narghile and QOL or PAQ data.
Discussion
Two age-, SL-, SEL- and quantity of used tobacco- matched
groups were compared: 63 ENS and 54 ECS. Compared to
the ENS group, the ECS one has a worse QOL with signifi-
cantly higher ‘‘activities”, ‘‘impact” and ‘‘total” scores, has sig-
nificantly lower sporting and PA scores, but includes similar
percentages of non-active subjects. Therefore, the null hypoth-
esis, that there is no divergence between the QOL and/or PA
scores of the two groups, is discarded. There were clear nega-
tive dose–effect relationships between sporting, leisure and
PAs scores and quantity of cigarettes smoked (the higher the
dose of cigarettes, the lower the PAs scores). However, no sig-
nificant relationship was found between quantity of narghile
usage and QOL or PA data.
Figure 1 Used quantities of tobacco (narghile-years or pack-
years) by exclusively-narghile-smokers (ENS, n= 63) and exclu-
sively-cigarette-smokers (ENS, n= 54) groups divided by age
ranges. Data are mean ± SD. n (X/Y) is the number of ENS/ECS.
*p< 0.05 (t-test): narghile-years vs. pack-years for each age range.
ns: not significant. ENS: . ECS: 4.
Table 1 Characteristics of the two groups of exclusive-narghile-smokers (ENS) and exclusive-cigarette-smokers (ECS).
ENS (n= 63) ECS (n= 54)




Tobacco-years (PY or NY) 30 ± 32 (22–38) 37 ± 34 (28–47)
Schooling-level Low 44 (69.8) 31 (57.4)
High 19 (30.1) 23 (42.6)
Socioeconomic-level Low 42 (66.7) 29 (53.7)
High 21 (33.3) 25 (46.3)
Narghile tobacco Tombac 26 (41.3)
Moassel 16 (25.4)
Jurak 9 (14.3)
Tombac and Moassel 5 (7.9)
Tombac and Jurak 3 (4.8)
Moassel and Jurak 2 (3.2)
Three types 2 (3.2)
Age and tobacco data are mean ± SD (95% confidence interval). Schooling and socioeconomic levels and narghile tobacco data are numbers
(%). *p< 0.05 (test-t): ENS vs. ECS. #p< 0.05 (Chi-2): ENS vs. ECS.
No significant difference were found between the two groups.
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data highlighted in the present study are part of a more univer-
sal phenomenon [1,2,4,25]. Studies analyzing ENS QOL and/
or PA data are scarce, totaling only four [12–15]. Their charac-
teristics and results are displayed in Tables 1s and 2s in the
Supplementary data section. In the 2015 systematic review of
health effects associated with narghile-use [1], the authors sta-
ted that ‘‘narghile-smoking was linked with lower overall
HRQOL in a cross-sectional study of 1675, past adjusting
for cigarette smoking and other parameters [15]” and con-
cluded that ‘‘the findings of these single reports require further
verification”.Study designs
Unlike the four published studies [12–15], the present study is
case–controlled. In their cross-sectional study, including 70
ENS, Ben Saad et al. [12] have compared data of a subgroup
of 40–60-Y-old ENS (n= 25) with those of an age-matched
HNS group (n= 53). Case–control studies are somewhat eco-
nomical and can be carried out by small groups in single con-
veniences. However, their results may be perplexed by a variety
of affective factors to the extent that they can give answers dif-
ferent to those given in other studies.
Sample size
The present case–control study sample size (n= 117; 63 ENS)
is estimated to be satisfactory. It is higher than that of Ben Saad
et al. [12] (n= 78; 25 ENS) and lower than those of the three
other published cross-sectional studies (Tables 1S and 2S).
However, as done in another study [12], the present one sample
size was calculated according to a predictive equation [23].
Applied questionnaires
Some other questionnaires were applied in similar studies
(Tables 1S and 2S). For QOL evaluation, an Arabic version
of the CCQ [26] and a Persian version [16] of the short-form-
health-survey (SF-36) [27] were applied (Table 2S). The SGRQ
is a self-reported disease-specific HRQOL questionnaire
[21,22]. It was developed originally to measure the impact of
COPD and asthma on a person’s life and health, but has also
been studied and applied to non-COPD pulmonary populations
[21,22]. For the PA status evaluation, an Arabic version of the
Voorrips PAQ [17] and the MABAT youth questionnaires [28]
were previously applied (Table 1S). The Voorrips PAQ [17] is
validated for applying in ‘‘free living” and apparently well being
people. It gives a consistent and valid method for categorizing
subjects into classes of high, medium, and low PA [17].
Table 2 Physical activity scores and status of the two groups of exclusive-narghile-smokers (ENS) and exclusive-cigarette-smokers
(ECS).
ENS (n= 63) ECS (n= 54) Percentage change










Daily 1.74 ± 0.56 (1.60–1.88) 1.70 ± 0.56 (1.54–1.85) +2
Physical 17.11 ± 8.46 (14.98–19.24) 13.71 ± 6.99 (11.80–15.61) +25*
Physical activity status Low (non-active) 13 (20.6) 15 (27.8)
Moderate 13 (20.6) 22 (40.7) #
High 37 (58.8) 17 (31.5) #
Moderate and high (active) 50 (79.4) 39 (72.2)
Sporting, leisure, daily and physical activities scores data are mean ± SD (95% confidence-interval).
Physical activity status data are number (%). Percentage change = (ENS value  ECS value)/ENS value.
* p< 0.05 (test-t): ENS vs. ECS.
# p< 0.05 (Chi-2): ENS vs. ECS.
Table 3 Quality-of-life scores of the two groups of exclusive-
narghile-smokers (ENS) and exclusive-cigarette-smokers
(ECS).
ENS (n= 63) ECS (n= 54) Percentage change




















Sporting, leisure and daily and physical activities scores data are
mean ± SD (95% confidence interval). Percentage change = (ENS
value  ECS value)/ENS value.
* p< 0.05 (test-t): ENS vs. ECS.
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The results in the present study are subject to some limitations.
The first limitation concerns the convenience sampling whose
main disadvantages are the risk that the sample might not rep-
resent the population as a whole, and the results might suggest
a bias in the responses from volunteers [9]. The second limita-
tion concerns lack of information about any data concerning
subjects’ chronic diseases. In practice, when comparing NS
and CS and analyzing the divergences between them, one
should keep in mind that CS might demonstrate a higher fre-
quency of chronic diseases in comparison to NS [15], and this
results in poorer QOL. The third limitation, as seen in a similar
study [14], concerns self-reporting data. This is topic to mis-
take since counting respondent over-reporting of socially desir-
able answers (social desirability response bias). The last
limitation concerns the non evaluation of other criteria (eg.;
heating a house by diesel fuel or by hot air, passive smoking,
occupational environment) that could influence the results.
Physical-activity of ENS
Compared to the ENS group, the ECS group has significantly
lower sporting and PA scores but includes similar percentagesof active and non-active subjects (Table 2). The negative
impact of cigarette smoking on PA among adults is well doc-
umented [29,30] and only two studies have evaluated the effect
of narghile-use on PA of children [14] and adults [12] – and
these have produced controversial results. In Nitzan Kaluski
et al. study [14], narghile-use, but not cigarette smoking, was
found to be connected with less optimal intensity of PA among
boys, although it was important merely among non-Jewish
boys. Jewish and non-Jewish NS boys were found to be 0.78
and 0.64 times less likely to be optimally active compared with
their Non-NS counterparts. Nevertheless, this relationship dis-
appeared among Jewish boys and just failed to be significant
among non-Jewish boys (odd-ratio = 0.59) when adjusted
for all other parameters included in the regression model. Lack
of relationship between cigarette smoking and PA might be
due to the low occurrence of cigarette smoking or the higher
dose of nicotine in narghile as compared to cigarettes, or other
confusing factors, for example, the use of supplementary drugs
such as hashish [14,31]. In Ben Saad et al. study [12], one fifth
of the 70 ENS were sedentary. Their ‘‘leisure activity” median
(1st–3rd quartiles) was four (3–6) and their ‘‘daily”, ‘‘sporting”
and ‘‘PA” scores mean ± SD were, respectively; 1 ± 1; 9 ± 6
and 16 ± 7. These data are generally lower than the present
study ENS scores (Table 1), and could be explained by a higher
amount of narghile tobacco consumed (Table 1S). In the pre-
vious study, authors [12] compared PA scores of a subgroup of
ENS (n= 25) with those of a HNS group (n= 53): the ENS
was found to have significantly lower ‘‘sporting”, ‘‘leisure”
and ‘‘PA” activities, but a similar, ‘‘daily” activity score
(Table 1S). PAQ data were negatively correlated only with
quantity of used cigarettes: the higher the dose of cigarette
smoking the lower were some PA scores (Table 4). Lack of cor-
relation between the PAQ data and quantity of narghile used is
surprising, since in a previous study [12], a higher quantity of
narghile resulted in a lower 6-min walk-distance, a parameter
reflecting objectively PA data [24]. However, in 104 HNS Tuni-
sian men aged 40 years and above, the 6-min walk-distance
was not significantly correlated with the PA score [24].
Quality-of-life
Narghile-use is associated significantly with poorer health per-
ception. However, compared to the ENS group, the ECS
Table 4 Correlation-coefficient between used quantity of
tobacco and physical activities or quality-of-life scores of the
two groups of exclusive-narghile-smokers (ENS) and exclusive-
cigarette-smokers (ECS).
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the two groups higher than the minimally-clinically-important-
difference (MCID= 4) [22] (Table 3). The present study
results are not surprising since the SGRQ is a respiratory
disease-specific questionnaire [22] and chronic ENS has less
undesirable effects on respiratory function tests than chronic
ECS [9]. Comparison of plethysmographic data of two, age
and height matched groups (36 ENS and 106 ECS of more
than 10 NY or 10 PY) found that the ECS group had lower
flows and volumes and higher frequencies of subjects with
obstructive-ventilatory-defect or with lung-hyperinflation.
The present study results are similar to that previously shown
by an Iranian population-based study [15], and are opposite to
those reported by a Lebanese study [13]. The Iranian study [15]
showed that the SF-36 mean scores of NS, for seven out of
eight dimensions, were lower than those of Non-S, signifying
that NS had a considerably worse health status than Non-S
in all scales except for ‘‘role limitations due to emotional prob-
lems” scale (Table 2S). The scores for each decreased scale of
NS compared to Non-S decreased by more than five points,
and this is clinically significant [15]. The Lebanese study [13]
showed that the previous and current CS vs. Non-S have sig-
nificantly lower QOL (evaluated via the CCQ [27]) in the same
disease category, however, previous and current NS vs. Non-S
have similar QOL. Since earlier studies have established that
socio-demographic characteristics could impact HRQOL
[32–34], it was argued that observed disparities between NS
and CS might be due to existing divergences in their socio-
demographic characteristics [13]. This hypothesis could not
be retained in the present study, since the two groups were
SL- and SEL-matched (Table 1). However, to correctly answer
this question, multivariate logistic regression analysis was nec-
essary [15]. Tavafian et al. [15] have verified the interactions
between narghile-use and other independent variables, includ-
ing age, sex, SL, occupational status, marital status, and cigar-
ette smoking status, and they have shown that narghile-use
could increase the risk of both physical and mental impair-
ment, independent of other socio-demographic characteristics.
No significant relationship was found between QOL data and
quantity of consumed narghile or cigarettes (Table 4). The pre-
sent result is opposite to that of Joseph et al. [13] where posi-
tive dose–effect relationships were found between differentsmoking types cumulative doses and QOL score (Table 2S).
In addition, cumulative cigarette and narghile doses were
found to be a predictor of respiratory QOL of a sample of
healthy, COPD and chronic bronchitis subjects [13].
In conclusion, chronic exclusive narghile-use is less detri-
mental to PA and QOL than chronic exclusive cigarette
smoking.
Recommendations
Smoking (including narghile-use) needs to be discouraged for
causes of universal health encouragement [4,25] and because
it reduces physical fitness [12]. As done by Tavafian et al.
[15], the authors also recommend research to test the social
desirability bias, and this should be done by taking a sub-
sample and comparing a subjective fitness measurement (ques-
tionnaires) with objective measures of exercise tolerance. This
can be done by means of pedometers to measure the level of
the activity over a particular episode of time [35]. Therefore,
given the harmful effects of narghile-use on PA and QOL,
more research in different target populations, with larger tar-
get populations and larger samples are needed to confirm these
results.
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